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Abstract
Introduction
• Herpes Zoster Virus (HZV) of the retina is a painless 
process that can progress very rapidly. HZV attacking the 
retina leads to Acute Retinal Necrosis (ARN) causing very 
devastating effects risking both the short term and long 
term outcomes of a patient’s visual acuity.
Research Question
Literature Review
Applicability to Clinical 
Practice
Acknowledgements
Discussion
• When a patient is presenting with signs of Acute Retinal 
Necrosis, there will need to be a rapid treatment course in 
order to preserve the patient’s long term visual outcome. 
• The course of this treatment will not be one that will only 
require a few days of treatment, this will be a treatment 
course that will require dedication and patience on both 
the patient as well as the provider as this may last for 
months to years. Depending on the causative agent, there 
may be relapses from time to time that will require need 
for immediate evaluation and possible treatment. 
• The vitreous inflammation that occurs in these relapses  
increases the intraocular pressure causing several other 
ocular problems. These problems include but not limited 
to optic nerve damage, posterior subcapsular cataract 
(PSC) formation, cystoid macular edema (CME), and 
vasculitis associated macular degeneration
• Acute Retinal Necrosis (ARN) can have extremely 
devastating effects on the vision of both healthy and 
immunocompromised individuals. Many times the 
exact pathogen of ARN can remain a mystery due to 
its silent and sometimes sudden onset along with the 
loss of vision prior to vitreal biopsy. One of the known 
pathogens is the Herpes Zoster Virus (HZV). 
• When Herpes Zoster Virus attack the retina, there are 
very devastating effects due to ARN including long 
term complications and blindness. A review of 
literature looked at the retrospective studies related to 
the incidence and prevalence of ARN caused by HZV. 
With an incidence of 1 case per 1.6 – 2.0 million 
population per year (Papageorgiou, Ch'ng, Kulkarni, 
Anwar, & Empeslidis, 2014), Acute Retinal Necrosis 
(ARN) can have extremely devastating effects on the 
vision of both healthy and immunocompromised 
individuals. A correlation of ARN and HZV might 
explain the complications and treatments related to 
herpes zoster of the retina. The results show how 
multiple healthcare providers can quickly identify and 
seek specialized treatment to preserve the patient’s 
eye site. These results indicate that there are more 
detrimental eye related conditions that are associated 
with herpes zoster virus than previously thought and 
how seeking coordinated specialized treatment can 
minimize the long term complications. 
• In adult patients with sudden onset visual 
disturbances caused by acute viral retinitis, does 
immediate surgical intervention along with an antiviral 
agent have a more favorable outcome than antiviral 
agents alone.
• Reviewing the literature, shows that the earlier the patient is 
evaluated and the referral to an ophthalmologists that 
specializes in disorders of the posterior aspect of the eye, the 
patient will have a more favorable outcome. The longer the 
patient is delayed in their treatment, the more damage will be 
done to the retina decreasing the best visual acuity in the long 
term. 
• Cochran et al, 2011, is a 14 month prospective study that was 
performed by the British Ophthalmological Surveillance Unit in 
order to find the incidence of ARN. With the 45 patients that 
were reported, 38 experienced unilateral involvement. 7 had 
bilateral involvement either simultaneously or experienced 
second eye involvement within a 3 month period after the initial 
presentation. The most common causative agent in the ARN 
was reported to be Varicella Zoster Virus. Other causative 
agents include  CMV, HSV 1 & 2, VZV, toxoplasmosis, Epstein-
Barr virus, and Syphilis. 
• Testing that can be performed for the confirmation of the virus 
that is the most common causes for ARN is polymerase chain 
reaction (PCR) of a small amount of vitreous fluid (Takase et al., 
2015) under general anesthesia in a surgical suite.
• However the exact causative agent is not necessary for 
treatment as the treatments are the same. Virostatic drugs 
should be started immediately and then corticosteroids should 
be added no earlier than 24-48 hours after the antiviral 
medications. (Mach et al., 2012)
• Roy et al., 2014, is a study of that was done retrospectively 
over a 10 year period with a total of 62 eyes out of 53 patients 
diagnosed with ARN. The outcomes varied with all of the 
patients started immediately on antiviral therapy, both oral and 
intravenous and was followed by a course of oral steroids. The 
final viral diagnosis was HSV in 19 patients (30.60%) and VZV 
in 28 (45.16%). There was retinal detachment in 66.12 % (41 
eyes).  Favorable final outcomes were seen in 28 of the 62 eyes 
(45.1%). The treatment needs to be quick and aggressive to 
increase the rates of the favorable outcome of ARN, a fulminate 
disorder.  (Roy et al., 2014)).
• The preferred antiviral medication for these injections is 
Foscarnet since it reaches the target area with the highest 
concentration. This treatment is one that decreases the 
progression of the disease damage to the retina as well as 
decreases the inflammation that occurs in the vitreous humor. 
(Cochrane et al., 2012)
• When it comes to treatment of ARN, early diagnosis is 
cornerstone treatment and can lead to the best outcomes. 
(Pikkel & Pikkel, 2014)
• How a PCP would initially suspect would be a patient that 
is seen in the office for visual changes in one or both eyes 
with or without a minimal amount of pain, anterior uvulitis, 
or a rapid increase in number or the new presence of 
“floaters” in the eye. 
• As a primary care provider, a call to an ophthalmologist 
needs to be made quickly when there is any suspicion of 
Acute Retinal Necrosis. This call should include questions 
in regards to the diagnostic studies that the 
ophthalmologist would like to have drawn now as well as if 
there is an antiviral that the ophthalmologist would like 
started. The ophthalmologist will likely request that a CBC, 
CMP, and blood cultures be obtained as well as starting 
the patient on an antiviral medication to help prevent 
further damage.
• In ophthalmology, the patient will then be evaluated for the 
severity of the disease and the course of treatment will 
then be initiated. In the severe cases with the necrosis 
showing around the entire periphery of the retina, the 
patient will likely be taken to the OR for vitreal biopsy(ies) 
and given intravitreal antiviral flushing with a vitrectomy
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Statement of the Problem
• Acute Retinal Necrosis can be a devastating disease that 
can lead to very dramatic lifestyle changes due to 
permeant vision deficit and/or loss. The disease can show 
up suddenly and progress very rapidly as well. Some of 
its early onset of symptoms could potentially be dismissed 
to age related visual changes from posterior vitreal
detachment, however on fundal exam changes to the 
retina can be spotted leading the provider to take some 
prompt action. There is some speculation that some 
sudden vision loss in the adult population can be 
associated to ARN in patients that never received eye 
exams until after the retina had detached completely. 
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Upper image showing vasculitis and peripheral white patching. Lower Image showing white 
patches of necrosis in the temporal area.(Pikkel & Pikkel, 2014) 
Fundus photos. Upper left – At initial presentation. Upper Right - 1 week post 1st injection. 
Lower Left – 1 week after 4th injection. Lower Right – 1 month after the 5th injection 
